Related Subjects:
|X linked Agammaglobulinaemia (Bruton)
|X-linked lymphoproliferative disease (Children)
|Chediak Higashi syndrome
|Common variable immunodeficiency
|Severe combined immunodeficiency disorders
|DiGeorge syndrome (thymic aplasia)
|Selective IgA deficiency
|Wiskott-Aldrich syndrome (Children)
|T lymphocytes
๐ About
- X-linked lymphoproliferative disease (XLP), also called Duncan disease, is a rare primary immunodeficiency that severely impairs the immune systemโs response to viral infections, especially EpsteinโBarr virus (EBV).
๐งฌ Aetiology
- Caused by mutations in the SLAM-associated protein (SAP) gene (SH2D1A).
- ๐ SAP normally regulates SLAM (signalling lymphocyte activation molecule) on T and B cells.
- โ Loss of SAP โ dysregulated T- and B-cell interactions โ uncontrolled immune responses, particularly to EBV.
- ๐ฉบ HSCT (bone marrow transplant) from an HLA-identical donor can restore normal immune function.
๐ฉบ Clinical Features
- โ ๏ธ Extreme sensitivity to EBV infection.
- EBV exposure may trigger severe or fatal infectious mononucleosis with massive immune activation.
- Risk of lymphoproliferative disorders (uncontrolled lymphocyte growth) and immune dysregulation.
- ๐ May progress to haemophagocytic lymphohistiocytosis (HLH), bone marrow failure, or liver disease.
๐ Investigations
- ๐งช Hypogammaglobulinemia (โ IgG, IgA, IgM) due to impaired B-cell function.
- โฌ๏ธ High risk of EBV-driven B-cell lymphomas, especially Burkitt lymphoma.
- ๐ Genetic testing confirms SH2D1A/SAP mutation.
โ๏ธ Management
- ๐ HSCT (haematopoietic stem cell transplantation) = only curative therapy; ideally performed early.
- ๐จ Aggressive management of acute EBV infections is lifesaving.
- ๐งช Immunoglobulin replacement therapy helps reduce infections in those with hypogammaglobulinemia.
- โ๏ธ Supportive care: antivirals, chemotherapy for EBV-associated lymphomas, HLH-directed therapy if needed.
๐ก Exam tip:
Think XLP in a young boy with fatal EBV mononucleosis, hypogammaglobulinemia, or early-onset lymphoma.
Distinguish from other immunodeficiencies: XLP is unique for its EBV-triggered catastrophic responses.